1. Home
  2. SOTK vs IMUX Comparison

SOTK vs IMUX Comparison

Compare SOTK & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sono-Tek Corporation

SOTK

Sono-Tek Corporation

HOLD

Current Price

$4.08

Market Cap

68.8M

Sector

Technology

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$1.19

Market Cap

75.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOTK
IMUX
Founded
1975
2016
Country
United States
United States
Employees
N/A
66
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.8M
75.2M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
SOTK
IMUX
Price
$4.08
$1.19
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
N/A
$4.25
AVG Volume (30 Days)
29.0K
4.3M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
0.08
N/A
Revenue
$20,504,381.00
N/A
Revenue This Year
$4.02
N/A
Revenue Next Year
$10.95
N/A
P/E Ratio
$53.00
N/A
Revenue Growth
4.08
N/A
52 Week Low
$3.23
$0.51
52 Week High
$5.15
$1.35

Technical Indicators

Market Signals
Indicator
SOTK
IMUX
Relative Strength Index (RSI) 45.07 76.19
Support Level $4.03 $0.61
Resistance Level $4.32 N/A
Average True Range (ATR) 0.23 0.12
MACD -0.00 0.02
Stochastic Oscillator 8.78 95.79

Price Performance

Historical Comparison
SOTK
IMUX

About SOTK Sono-Tek Corporation

Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: